Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Walgreens Boots Alliance, Inc. WBA NASDAQ

NASDAQ Global Select • Healthcare • Medical - Pharmaceuticals • US • USD

SharesGrow Score
24/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.00
-24.9%

Walgreens Boots Alliance, Inc. (WBA) is a Medical - Pharmaceuticals company in the Healthcare sector, currently trading at $11.98. It has a SharesGrow Score of 24/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Analyst consensus target is WBA = $9 (-24.9% upside).

Financials: revenue is $147.7B, +3.7%/yr average growth. Net income is $8.6B (loss), growing at -93.6%/yr. Net profit margin is -5.8% (negative). Gross margin is 18% (-3.2 pp trend).

Balance sheet: total debt is $32.9B against $10.4B equity (Debt-to-Equity (D/E) ratio 3.15, leveraged). Current ratio is 0.68 (tight liquidity). Debt-to-assets is 40.5%. Total assets: $81.0B.

Analyst outlook: 5 / 31 analysts rate WBA as buy (16%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 10/100 (Fail), Growth 30/100 (Fail), Past 50/100 (Partial), Health 0/100 (Fail), Moat 51/100 (Partial), Future 16/100 (Fail), Income 10/100 (Fail).

$9.00
▼ 24.87% Downside
Average Price Target
The 12-month price target for Walgreens Boots Alliance, Inc. is $9.00.

WBA SharesGrow Score Overview

28/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 10/100
Valuation — P/E, PEG, Forward PEG
GROWTH 30/100
Financials — average growth
PAST 50/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 51/100
Gross margin is + market cap
FUTURE 16/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — WBA

✗
VALUE Fail
10/100
WBA trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $9, implying -24.9% from the current price $12. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✗
GROWTH Fail
30/100
WBA: +3.7%/yr revenue is, -93.6%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
50/100
WBA: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.
View details →
—
HEALTH N/A
N/A
No analyst coverage available for this stock.
~
MOAT Partial
51/100
WBA: Gross margin is 18% (-3.2 pp trend), $10B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 51/100. ≥ 70 = Pass.
View details →
✗
FUTURE Fail
16/100
Analyst outlook: 5 / 31 analysts rate WBA as buy (16%). Analyst consensus target is $9 (-24.9% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
WBA: Net profit margin is -5.8%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range8.08-13.25
Volume452.08M
Avg Volume (30D)16.94M
Market Cap$10.37B
Beta (1Y)0.77
Dividend Yield$0.2500
Share Statistics
EPS (TTM)-10.01
Shares Outstanding$863.1M
IPO Date1980-03-17
Employees193,000
CEOTimothy C. Wentworth
Financial Highlights & Ratios
Revenue (TTM)$147.66B
Gross Profit$26.52B
EBITDA$-11.28B
Net Income$-8.64B
Operating Income$-14.08B
Total Cash$3.11B
Total Debt$32.85B
Net Debt$31.53B
Total Assets$81.04B
Price / Earnings (P/E)-1.2
Price / Sales (P/S)0.07
Analyst Forecast
1Y Price Target$9.00
Target High$9.00
Target Low$9.00
Upside-24.9%
Rating ConsensusHold
Analysts Covering31
Buy 16% Hold 55% Sell 29%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS9314271084

Price Chart

Track all markets on TradingView
WBA
Walgreens Boots Alliance, Inc. ↗  ·  NASDAQ Global Select
Healthcare • Medical - Pharmaceuticals
8.08 52WK RANGE 13.25

People Also View

HITI
HITI
High Tide Inc.
$2.34
+0.43%
 LFLY
LFLY
Leafly Holdings, Inc.
$37.00
+0.00%
 YI
YI
111, Inc.
$6.81
+0.29%
 PETS
PETS
PetMed Express, Inc.
$2.35
+2.17%
 RAD
RAD
Rite Aid Corporation
$0.65
-16.81%
 MEDS
MEDS
TRxADE HEALTH, Inc.
$7.59
+4.55%
 CJJD
CJJD
China Jo-Jo Drugstores, Inc.
$1.52
-5.59%
 SSY
SSY
SunLink Health Systems, Inc.
$1.12
+16.15%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message